Skip to main navigation Skip to search Skip to main content

Accelerated bottom-up drug design platform enables the discovery of novel stearoyl-CoA desaturase 1 inhibitors for cancer therapy

  • Christina A. von Roemeling
  • , Thomas R. Caulfield
  • , Laura Marlow
  • , Ilah Bok
  • , Jiang Wen
  • , James L. Miller
  • , Robert Hughes
  • , Lori Hazlehurst
  • , Anthony B. Pinkerton
  • , Derek C. Radisky
  • , Han W. Tun
  • , Yon Son Betty Kim
  • , Amy L. Lane
  • , John A. Copland
  • Center for the Science of Health Care Delivery
  • University of North Florida

Research output: Contribution to journal › Article › peer-review

Original languageEnglish
Pages (from-to)3-20
Number of pages18
JournalOncotarget
Volume9
Issue number1
DOIs
StatePublished - 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus Subject Areas

  • Oncology

Keywords

  • Cancer
  • Drug discovery
  • High throughput drug screening
  • Lipid metabolism
  • Stearoyl CoA desaturase

Fingerprint

Dive into the research topics of 'Accelerated bottom-up drug design platform enables the discovery of novel stearoyl-CoA desaturase 1 inhibitors for cancer therapy'. Together they form a unique fingerprint.

Cite this